Giving Patients with Erectile Dysfunction the Opportunity to Try All Three Available Phosphodiesterase Type 5 Inhibitors Contributes to Better Long-Term Treatment Compliance

To let patients with ED test the three available PDE5 inhibitors results in an unusually high compliance even under an extended period of time (>2 years). Ljunggren C, Hedelin H, Salomonsson K, and Ströberg P. Giving patients with erectile dysfunction the opportunity to try all three available phosphodiesterase type 5 inhibitors contributes to better long-term treatment compliance.